Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 12 of 25
Neural Correlates of Knee Sensorimotor Control in Patients With Patellofemoral Pain Syndrome
NCT04099004
Neostigmine For Snoring During DISE
NCT03316963
A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
NCT03043300
Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only
NCT02646579
Treatment of Encopresis in Children With Autism Spectrum Disorders
NCT03197922
Thyroid Ultrasound Elasticity (TrUE) Imaging
NCT03307694
Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism
NCT03086317
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer
NCT02766478
Open Trial Obesity CHANGE Program ASD
NCT03047018
App Reminder on ASA Adherence
NCT03244267
Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt
NCT03043339
Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women
NCT03165747
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
NCT03137888
Evaluation of an Intervention to Increase Post-abortion LARC Uptake.
NCT03214848
Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration
NCT03014037
A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes
NCT03616171
Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
NCT03251495
Usability and Tolerability of Novel Protection Device Against Potential Brain Injury During Competitive Sport
NCT03318822
Intranasal (NAS) Ketamine for Cancer Pain
NCT03146806
The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project
NCT03308812
Microneedle Patch Study in Healthy Infants/Young Children
NCT03207763
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
NCT03095781
Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction
NCT03018106
A Low ChloridE hyperTonic Solution for Brain Edema
NCT03204955
PreTeenVax Evaluation
NCT03186430
Cryoablation for Obesity Management
NCT03092778
P3+ Intervention Phase
NCT02898688
SMS-Based Follow-Ups to Improve Post-Discharge Surgical Outcomes
NCT03161262
Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic
NCT03831555
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
NCT01489813
Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers
NCT03033875
Glargine U300 Hospital Trial
NCT03013985
Inflammation-Induced CNS Glutamate Changes in Depression
NCT03004443
Pregnancy With Morquio Syndrome - What Are Patients' Perspectives and Has ERT Changed Them?
NCT03150069
Autism Oxytocin Brain Project
NCT03033784
Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder
NCT02992899
Engaging Patients With Mental Disorders From the ED in Outpatient Care
NCT02989805
Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients
NCT03040024
Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease
NCT03081884
Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy
NCT03078452
Promoting Quality of Life Among Young Adult Cancer Survivors
NCT03446105
Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
NCT02985996
Amniotic Membrane for Donor Site Healing
NCT02947737
Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
NCT02964559
Women Empowered to Live With Lupus Study
NCT02988661
Water Versus Saline as Irrigation Fluid for Ureteroscopy
NCT03794102
Transfusion of Biotinylated Red Blood Cells
NCT02757898
Tailoring of Vaccine-Focused Messages: Disease Salience
NCT03002324
Gabapentin as an Adjunct to Paracervical Block for Perioperative Pain Management
NCT02944656
FMT for MDRO Colonization After Infection in Renal Transplant Recipients
NCT02922816
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.